Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & Energy
Key factors driving the growth of this market include ongoing technological advancements in the field of infectious disease diagnosis, rising incidence of infectious diseases and growing outbreak of epidemics, and increased funding and public-private investments for research and innovation.
North America is expected to hold the largest share of the global clinical microbiology market in 2018, however, Asia Pacific is expected to grow at the fastest rate during the forecast period.
Market Analysis and Insights: Global Microbiology Testing/Clinical Microbiology Market
The global Microbiology Testing/Clinical Microbiology market size is projected to reach US$ 3214.4 million by 2026, from US$ 3062.3 million in 2020, at a CAGR of 4.6%% during 2021-2026.
Global Microbiology Testing/Clinical Microbiology Scope and Market Size
Microbiology Testing/Clinical Microbiology market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Microbiology Testing/Clinical Microbiology market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Biomerieux
Danaher
Becton, Dickinson
Abbott Laboratories
Roche Diagnostics
Bruker
Hologic
Bio-Rad Laboratories
Qiagen
Thermo Fisher Scientific
Agilent
Merck Kgaa
3M
Neogen
Laboratory Equipment
Microbiological Analyzer
Pathogen Kits
General Reagent
Digestive Tract Disease
Sexually Transmitted Disease
Urinary Tract Infection
Periodontal Disease
Other
North America
Europe
China
Japan
Southeast Asia
India
North America is expected to hold the largest share of the global clinical microbiology market in 2018, however, Asia Pacific is expected to grow at the fastest rate during the forecast period.
Market Analysis and Insights: Global Microbiology Testing/Clinical Microbiology Market
The global Microbiology Testing/Clinical Microbiology market size is projected to reach US$ 3214.4 million by 2026, from US$ 3062.3 million in 2020, at a CAGR of 4.6%% during 2021-2026.
Global Microbiology Testing/Clinical Microbiology Scope and Market Size
Microbiology Testing/Clinical Microbiology market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Microbiology Testing/Clinical Microbiology market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Biomerieux
Danaher
Becton, Dickinson
Abbott Laboratories
Roche Diagnostics
Bruker
Hologic
Bio-Rad Laboratories
Qiagen
Thermo Fisher Scientific
Agilent
Merck Kgaa
3M
Neogen
Market segment by Type, the product can be split into
Laboratory Equipment
Microbiological Analyzer
Pathogen Kits
General Reagent
Market segment by Application, split into
Digestive Tract Disease
Sexually Transmitted Disease
Urinary Tract Infection
Periodontal Disease
Other
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
